title: Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.
abstract: OBJECTIVE
  We evaluated morphological, biochemical and cytological thyroid parameters in acromegalic patients, investigated before and after treatment for acromegaly.
  
  
  METHODS
  28 acromegalics were investigated before and, in 18 cases, after 2-7 years of therapy. Fourteen patients were from areas of moderate iodine deficiency in Southern Italy. One patient underwent thyroidectomy before entering this study.
  
  
  RESULTS
  19 patients were euthyroid (FT4: 17.7 +/- 0.8 pmol/l and FT3 4.6 +/- 0.2 pmol/l), but TSH was undetectable in 5/19. Among them, TRH-stimulated TSH increase was absent/impaired or exaggerated/delayed in 9 and one cases, respectively. Decreased FT3 and/or FT4 values with low/normal TSH values were detected in 7 cases; TRH-stimulated TSH response was absent/impaired in 2 patients and exaggerated/delayed in another two. Increased free T4 and free T3 concentrations with undetectable TSH levels were found in one. Two euthyroid patients had high TPOAb levels. Goiter was diagnosed in 21 cases and nodules were found in 14/21. 99Tc scintiscan showed "cold" areas in 13/14 cases and a "hot" nodule in the hyperthyroid patient. Acromegalics from iodine deficient areas showed a not significant increase of prevalence of goiter (86 vs. 71 %) and of mean thyroid volume (35 +/- 7 vs. 28 +/- 4 ml, NS), compared to others. Thyroid volume (TV) did not correlate with GH, IGF-1 and TSH levels, the area under the curve of insulin-increase during OGTT, the age of patients or the duration of acromegaly. Fine needle aspiration biopsy (FNAB), performed in 11/14 patients with nodular goiter, showed colloid nodules in 8 cases, hyperplastic nodules in 2 and an adenomatous nodule in one. Neurosurgery, radiotherapy or medical treatment for acromegaly induced a significant decrease of mean GH and IGF-1 levels (21.5 +/- 8.5 vs. 12.9 +/- 9.6 ng/ml, p< 0.005 and 747 +/- 94 vs. 503 +/- 88 ng/ml, p < 0.02, respectively), but both GH and IGF-1 values normalized only in 3 cases. No significant variation of mean TSH levels was found. Although TV normalized in 3 patients, ultrasound evaluation showed a not significant decrease of mean TV and no changes in the diameter and number of nodules. FNAB was unchanged.
  
  
  CONCLUSIONS
  Our results suggest that, despite no correlation between serum GH and IGF-1 levels and thyroid volume being found, a decrease in serum GH and IGF-1 levels has favourable effects on thyroid status.
authors.affiliation: Cattedra di Endocrinologia, University of Messina, Italy. endocrinologi@hotmail.com
authors.forename: S
authors.initials: S
authors.lastname: Cannavò
authors.forename: S
authors.initials: S
authors.lastname: Squadrito
authors.forename: M D
authors.initials: MD
authors.lastname: Finocchiaro
authors.forename: L
authors.initials: L
authors.lastname: Curtò
authors.forename: B
authors.initials: B
authors.lastname: Almoto
authors.forename: A
authors.initials: A
authors.lastname: Vieni
authors.forename: F
authors.initials: F
authors.lastname: Trimarchi
mesh_terms: D000172:Acromegaly / Q000150:complications* / Q000209:etiology / Q000473:pathology*; D000236:Adenoma / Q000150:complications; D000328:Adult; D000368:Aged; D001706:Biopsy; D005260:Female; D005500:Follow-Up Studies; D006042:Goiter / Q000209:etiology* / Q000473:pathology*; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007455:Iodine / Q000172:deficiency; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000473:pathology / Q000502:physiology*; D013972:Thyrotropin / Q000097:blood
chemical_list: D007334:Insulin-Like Growth Factor I; D013972:Thyrotropin; D013006:Growth Hormone; D007455:Iodine